Author

Kelly Raybold

Institution: Janssen Research & Development (United States)

Observed institution: Janssen Research & Development (United States)

OpenAlex ID: A5015749670

Abstract CT236: A phase 1b, multicenter, randomized, blinded, placebo-controlled study to evaluate the efficacy of guselkumab in subjects with familial adenomatous polyposis

2020 · Eduardo Vilar-Sanchez, Carol Burke, et al. · Cancer Research · 1

Works count: 1

Citation count: 1

H-index: 1

I10-index: